Clinical Trial Update: Sodium Lowering and Urinary Protein Reduction Trial [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating sodium lowering for reducing urinary protein in chronic kidney disease with albuminuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Chronic Kidney Disease

Snippet

Sponsor: Tulane University School of Public Health and Tropical Medicine | Conditions: Chronic Kidney Disease, Albuminuria | Phase 3 | Status: COMPLETED